Rice Partnership’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Rice Partnership's REGN Position: Q3 2026 in Review
Rice Partnership opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 2,960 shares worth $2.24M. The stake represents 0.26% of the portfolio and ranks #57 among its holdings.
1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Rice Partnership held 2,960 shares of Regeneron Pharmaceuticals worth $2.24M as of Q3 2026.
- Regeneron Pharmaceuticals was a new Rice Partnership position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.26% of Rice Partnership's portfolio in Q3 2026, its #57 holding.
- 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Rice Partnership's 13F filing for Q3 2026, filed 9 Nov 2026.